Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease

doi:10.4292/wjgpt.v15.i6.95532

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1004)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

505

Figures (1-1)

Tables (1-3)

Sum=674

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

120

Sum=182

Publishing Process of This Article

Item

Count

Browse

Download

Sum=114

Nov 5, 2024 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Pharmacol Ther. Nov 5, 2024; 15(6): 95532
Published online Nov 5, 2024. doi: 10.4292/wjgpt.v15.i6.95532

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram depicting the distribution of study participants. IBD: Inflammatory bowel disease.

Citation: Changela M, Pandey S, Bahirwani J, Patel N, Kaneriya M, Basida SD, Shah A, Thakur R, Bodrya K, Jai Kumar Ahuja S, Schneider Y. Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2024; 15(6): 95532
URL: https://www.wjgnet.com/2150-5349/full/v15/i6/95532.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v15.i6.95532